Previous Page  12 / 15 Next Page
Information
Show Menu
Previous Page 12 / 15 Next Page
Page Background

Page 25

Volume 2

July 24-25, 2019 | Rome, Italy

World Hematology 2019 & Nursing Care 2019

July 24-25, 2019

Journal of Blood Disorders and Treatment

47

th

WORLD CONGRESS ON NURSING CARE

11

th

WORLD HEMATOLOGY AND ONCOLOGY CONGRESS

&

The heart of the matter: A unique convergence of cardiac neoplasm, hereditary

nonpolyposis colorectal cancer, and spindle cell sarcoma

Emily Bryer DO, Lee Hartner

Pennsylvania Hospital University of Pennsylvania School of Medicine, USA

P

rimary cardiac tumors are exceedingly unusual

and aggressive; they often develop in younger

patients and present with advanced disease. The

rarity and heterogeneity of primary cardiac tumors

challenge the standardization of therapeutic

guidelines. Undifferentiated primary cardiac spindle

cell sarcomas, a distinct subset of primary cardiac

sarcomas, are especially unique with fewer than 20

cases reported worldwide—the majority of which are

of left atrial origin. We present a review of the etiology,

pathophysiology, and therapy of undifferentiated

primary cardiac spindle cell sarcomas. In conjunction,

we present a unique case of a woman with hereditary

nonpolyposis colorectal cancer (Lynch syndrome) who

presented with a primary cardiac spindle cell sarcoma

of left ventricular origin, the first case of this type and location of cardiac tumor reported in a patient with Lynch syndrome. While

some malignancies are more common in patients with Lynch syndrome, sarcomas are not one of them. The absence of metastases

at the time of diagnosis is atypical for left-sided cardiac sarcomas, the overwhelming majority of which have metastases at the

time of diagnosis. In addition to anatomic and pathophysiologic distinctions of this case from other primary cardiac spindle cell

sarcomas, it also demonstrated unique immunohistochemistry as the first reported case of MDM-negative (murine double minute

homolog, a principle diagnostic marker of spindle cell sarcoma) ever reported.

Biography

Emily Bryer is a physician in Philadelphia, Pennsylvania USA. She attended the Schreyer Honors College of The Pennsylvania State

University for her undergraduate training where she served as President of Global Medical Brigades and established medical clinics in

areas of Ghana, Honduras, Nicaragua, and Panama with limited access to medical care and healthcare resources. She received her

medical degree from The Philadelphia College of Osteopathic Medicine before starting her Internal Medicine residency at Pennsylvania

Hospital of the University of Pennsylvania. Her research interests include venous thromboembolism in chemotherapy-induced anemia

and gestational trophoblastic disease.

Emily.Bryer@pennmedicine.upenn.edu

J Blood Disord Treat, Volume 2

Left atrium

Left ventricle

Right atrium

Right ventricle

Pericardium

7%

7%

7%